Ansell Ltd
Company Profile
Business description
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 60% of revenue and 70% of operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly across more than 100 countries. In fiscal 2022, Ansell earned 45% of revenue in North America, 33% from Europe, Middle East and Africa, 14% across Asia-Pacific and the remaining 8% in Latin America.
Contact
678 Victoria Street
Level 3
RichmondVIC3121
AUST: +61 392707270
E: zubair.javeed@ansell.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 June 2025
Employees
15,951
Stocks News & Analysis
stocks
3 cheap ASX shares with sound balance sheets
stocks
Ansell poised to return to growth
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,586.70 | 15.30 | 0.18% |
CAC 40 | 7,869.37 | 4.93 | 0.06% |
DAX 40 | 24,136.54 | 137.37 | 0.57% |
Dow JONES (US) | 41,859.09 | 1.35 | -0.00% |
FTSE 100 | 8,774.42 | 35.16 | 0.40% |
HKSE | 23,601.26 | 56.95 | 0.24% |
NASDAQ | 18,925.73 | 53.09 | 0.28% |
Nikkei 225 | 37,160.47 | 174.60 | 0.47% |
NZX 50 Index | 12,596.50 | 65.75 | -0.52% |
S&P 500 | 5,842.01 | 2.60 | -0.04% |
S&P/ASX 200 | 8,360.90 | 12.20 | 0.15% |
SSE Composite Index | 3,348.37 | 31.82 | -0.94% |